Iovance Biotherapeutics, Inc. (IOVA) total debt

Total debt · fiscal 2025
$49.44M

Iovance Biotherapeutics, Inc. (IOVA) carried total debt of $49.44M at the end of fiscal 2025 (December 31, 2025). That is 15.1% lower than the $58.26M of fiscal 2024. Figures as of 18 Nov 2026, 10:46 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$49.44M
Change on fiscal 2024
−15.1%
Highest on record
$85.45Mfiscal 2022
Lowest on record
$49.44Mfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Iovance Biotherapeutics, Inc. total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $85.45M in fiscal 2022 and the lowest $49.44M in fiscal 2025.

Total debt was 0.1× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Iovance Biotherapeutics, Inc. total debt, year by year

Iovance Biotherapeutics, Inc. (IOVA) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$49.44M 15.1% down0.1×
2024$58.26M 23.2% down0.1×
2023$75.86M 11.2% down0.1×
2022$85.45M—0.2×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on IOVA

Iovance Biotherapeutics, Inc., figure by figure

Iovance Biotherapeutics, Inc. (IOVA) overview: price, valuation and scorecard

Iovance Biotherapeutics, Inc. total debt: questions and answers

How much debt does Iovance Biotherapeutics, Inc. have?

Iovance Biotherapeutics, Inc. (IOVA) carried total debt of $49.44M at the end of fiscal 2025 (December 31, 2025). That is 15.1% lower than the $58.26M of fiscal 2024.

What are the highest and lowest total debt figures on record for Iovance Biotherapeutics, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was $85.45M in fiscal 2022 and the lowest $49.44M in fiscal 2025.

How does Iovance Biotherapeutics, Inc.'s debt compare with its equity?

Total debt was 0.1× shareholders' equity at the end of fiscal 2025.

How is Iovance Biotherapeutics, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Iovance Biotherapeutics, Inc. it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Iovance Biotherapeutics, Inc. (IOVA) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/IOVA/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.